hematopoietic system
|
• mice injected with pIpC to induce Pten deletion have an enlarged thymus
|
|
• mice injected with pIpC to induce Pten deletion have an enlarged spleen
|
neoplasm
|
• mice injected with pIpC to induce Pten deletion, develop myeloproliferative disease and T-cell acute lymphoblastic leukemia, but at a slower rate than in single Pten mutants
|
mortality/aging
|
• mean survival time of mice injected with pIpC to induce Pten deletion is 46 days
|
immune system
|
• mice injected with pIpC to induce Pten deletion have an enlarged thymus
|
|
• mice injected with pIpC to induce Pten deletion have an enlarged spleen
|
endocrine/exocrine glands
|
• mice injected with pIpC to induce Pten deletion have an enlarged thymus
|
growth/size/body
|
• mice injected with pIpC to induce Pten deletion have an enlarged spleen
|


Analysis Tools